SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000014
Filing Date
2024-06-10
Accepted
2024-06-10 16:11:34
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718050286.html 4  
1 FORM 4 wk-form4_1718050286.xml 4 5824
2 EX-24 poasection16filings-loxa.htm EX-24 4127
3 GRAPHIC poasection16filings-loxa001.jpg GRAPHIC 249663
  Complete submission text file 0001649094-24-000014.txt   355576
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Loxam Teri (Reporting) CIK: 0001829111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241032807